Article
Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
Human pathology - 1 Dec 2017
Schoolmeester J Kenneth, Moyer Ann M, Goodenberger McKinsey L, Keeney Gary L, Carter Jodi M, Bakkum-Gamez Jamie N
Abstract excerpt
Germline BRCA mutations account for a significant proportion of genetic/familial risk of breast and ovarian cancer (GBOC) susceptibility, but a broader spectrum of GBOC susceptibility genes has emerged in recent years. Genotype-to-phenotype correlations are known for some established forms of GBOC; however, whether such correlations exist for less common GBOC variants is unclear. We reviewed our institution's...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.